Abstract
Biological evidence supports plasma methemoglobin as a biomarker for anemia-induced tissue hypoxia. In this translational planned substudy of the multinational randomized controlled transfusion thresholds in cardiac surgery (TRICS-III) trial, which included adults undergoing cardiac surgery requiring cardiopulmonary bypass with a moderate-to-high risk of death, we investigated the relationship between perioperative hemoglobin concentration (Hb) and methemoglobin; and evaluated its association with postoperative outcomes. The primary endpoint was a composite of death, myocardial infarction, stroke, and severe acute kidney injury at 28 days. We observe weak non-linear associations between decreasing Hb and increasing methemoglobin, which were strongest in magnitude at the post-surgical time point. Increased levels of post-surgical methemoglobin were associated with a trend toward an elevated risk for stroke and exploratory neurological outcomes. Our generalizable study demonstrates post-surgical methemoglobin may be a marker of anemia-induced organ injury/dysfunction, and may have utility for guiding personalized approaches to anemia management.
Clinicaltrials.gov registration NCT02042898.
Original language | English |
---|---|
Article number | 107429 |
Number of pages | 12 |
Journal | iScience |
Volume | 26 |
Issue number | 8 |
Early online date | 20 Jul 2023 |
DOIs | |
Publication status | Published - 18 Aug 2023 |
Keywords
- Cardiovascular medicine
- Health sciences
- Public health
- Surgery